Please enable JS

Drug Pipeline

Title Published Pages Region Price
Nuclear Receptor ROR Gamma (Nuclear Receptor RZR Gamma or Nuclear Receptor Subfamily 1 Group F Member 3 or RAR Related Orphan Receptor C or Retinoid Related Orphan Receptor Gamma or RORC) - Pipeline Review, H1 2018 Jan 18 2018 96 Global $3,500.00
Anthrax - Pipeline Review, H1 2018 Jan 18 2018 109 Global $2,000.00
Microscopic Polyangiitis (MPA) - Pipeline Review, H1 2018 Jan 18 2018 42 Global $2,000.00
Hepatic Encephalopathy - Pipeline Review, H1 2018 Jan 18 2018 64 Global $2,000.00
Gastric Inhibitory Polypeptide Receptor (Glucose Dependent Insulinotropic Polypeptide Receptor or GIPR) - Pipeline Review, H1 2018 Jan 18 2018 41 Global $3,500.00
Traumatic Brain Injury - Pipeline Review, H1 2018 Jan 18 2018 270 Global $2,000.00
Fibromyalgia - Pipeline Review, H1 2018 Jan 18 2018 68 Global $2,000.00
Elephantiasis (Lymphatic Filariasis) - Pipeline Review, H1 2018 Jan 18 2018 22 Global $2,000.00
Sodium And Chloride Dependent Glycine Transporter 1 (Glyt1 or Solute Carrier Family 6 Member 9 or SLC6A9) - Pipeline Review, H1 2018 Jan 18 2018 35 Global $3,500.00
Frontier Pharma: Transplantation Therapeutics - A Highly Innovative Pipeline with a Range of Adaptive and Innate Immune-Targeting Programs Focusing on Graft-Versus-Host Disease and Kidney Transplantation Dec 1 2017 72 Global $6,995.00
Neuropsychiatric Disorder Cluster Drug Development Pipeline Review, 2017 Aug 1 2017 254 Global $3,995.00
Genetic Ophthalmology Disorders Drug Development Pipeline Review, 2017 Aug 1 2017 138 Global $3,995.00
Frontier Pharma: Cardiovascular Disease - Diverse First-in-Class Molecular Targets to Bridge Unmet Needs in Pulmonary Hypertension, Heart Failure and Atherosclerosis Aug 1 2017 113 Global $6,995.00
Hepatitis Drug Development Pipeline Review, 2017 Aug 1 2017 209 Global $3,995.00

Pages